Cardiomyopathy Clinical Trials in Guangzhou, Guangdong
4 recruitingGuangzhou, Guangdong, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled289 locationsNCT07207811
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb500 enrolled15 locationsNCT07361289
Recruiting
Not Applicable
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
Heart FailureCardiomyopathyCoronary Heart Disease (CHD)+5 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07154355
Recruiting
Not Applicable
ExtraCorporeal Membrane Oxygenation in the Therapy for REfractory Septic Shock With Cardiac Function Under Estimated
Cardiogenic ShockSeptic ShockExtracorporeal Membrane Oxygenation+1 more
Second Affiliated Hospital of Guangzhou Medical University64 enrolled1 locationNCT05184296